Latest News about IPSC
Recent news which mentions IPSC
Century Therapeutics's Return On Capital Employed Overview
March 20, 2023
Tickers
IPSC
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 19, 2023
From Benzinga
5 Health Care Stocks That Are Diving - And May Rally
January 19, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 12, 2023
From Benzinga
Top 5 Health Care Stocks That May Surge
January 10, 2023
From Benzinga
From InvestorPlace
Century Therapeutics Announces Internal Portfolio Prioritization, Analyst Views It As Incrementally Positive
January 06, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 27, 2022
December 27, 2022
From Benzinga
Arcus Biosciences, FuelCell Energy And Some Other Big Stocks Moving Lower On Tuesday
December 20, 2022
From Benzinga
Gamma Delta T Cell Therapy Market Could Reach $4 Billion As Biotechs Race To Get Breakthrough Cancer Treatment Approved
November 22, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
From Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 25, 2022
From Benzinga
FDA Announced Clearance To Century Therapeutics' Allogeneic Cell Therapy Candidate Study
August 25, 2022
Tickers
IPSC
From Benzinga
From Motley Fool
U.S. Stock Futures Higher Following Friday's Rally
June 27, 2022
From Benzinga
92 Biggest Movers From Friday
May 09, 2022
From Benzinga
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
February 08, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 01, 2022
From Benzinga
What's Behind Bristol Myers Squibb's Latest Partnership?
January 22, 2022
From Motley Fool
60 Biggest Movers From Yesterday
January 11, 2022
From Benzinga
45 Stocks Moving In Monday's Mid-Day Session
January 10, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 10, 2022
From Benzinga
Bristol Myers, Century Therapeutics Ink Pact For iPSC-Derived Allogeneic Cell Therapies
January 10, 2022
From Benzinga
51 Biggest Movers From Yesterday
December 28, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.